Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 1,269 $ 1,053
INVESTING ACTIVITIES    
Purchase of medical equipment and property (3,535) (1,120)
Proceeds from sale of medical equipment and property 764 955
NET CASH USED IN INVESTING ACTIVITIES (2,771) (165)
FINANCING ACTIVITIES    
Principal payments on term loans and capital lease obligations (929) (2,790)
Debt issuance costs (3)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (37)
Common stock repurchased as part of Repurchase Program (83)
Cash proceeds - stock plans 53 46
NET CASH USED IN FINANCING ACTIVITIES (916) (2,827)
Net change in cash and cash equivalents (2,418) (1,939)
Cash and cash equivalents, beginning of period 4,318 3,469
Cash and cash equivalents, end of period $ 1,900 $ 1,530